Why the study?
Despite the high disease burden of cardiovascular complications from hypertension, factors related to the progression to hypertension in normotensive populations are not actively reported.
In a large Korean cohort, nearly two-thirds of normotensive adults progressed to hypertension over 14 years, with age, BMI, and hemoglobin identified as key risk factors for progression.
Substantial progression rates call for enhanced surveillance in normotensives; leaves open optimal prevention strategies pending prospective trials.
BACKGROUND: Although the high disease burden that results from cardiovascular complications of hypertension, factors related to the progression to hypertension in the normotensive population are not actively reported. The purpose of this study was to estimate the rate of the progression to hypertension and to reveal the associated risk factors. METHODS: The study included normotensive participants from the National Health Insurance Service-National Health Screening Cohort, and contained a 10% sample of all adults who received a national health screening test in either 2002 or 2003. At the end of the study in 2015, the patients were divided into two groups based on whether or not they progressed to hypertension. Cox proportional hazard modeling was performed to identify risk factors for progression. Subgroup analysis using logistic regression was employed to reveal factors influencing the different natural history of the progression. RESULTS: Among the 75,335 included participants, the progression rate to hypertension was 66.39% (50,013), with an adjusted incidence rate of 8.62 per 100 person-year in the aged 40-64 group and 12.68 in the aged 65 or above group. Age, BMI, hemoglobin, and family history of hypertension and other diseases were related to the progression. Among the progression group, 78.21% (39,116) participants skipped a pre-hypertensive status; this group consisted of older females with lower pulse pressure and more alcohol consumption compared to people who had pre-hypertensive status before the progression. CONCLUSION: Substantial risk factors for the progression to hypertension should be carefully managed even in normotensive participants who receive health screening tests.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: